The Patent Finder

Genoscience Pharma SAS

Also on record
Records under this name other than patents Genoscience Pharma SAS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Genoscience Pharma SAS

PatentTitleStatus Expires Confidence
US 8,987,302Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
Lapsed on the fee record
Ended Mar 24, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 24, 2019From the USPTO record
US 8,575,195Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
Lapsed on the fee record
Ended Nov 5, 2017 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2017From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited